Avalo Therapeutics AVTX
NASDAQ AVTX
$14.95 -0.38 (-2.48%)
At close: Oct 1, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Other Non-Current Assets (2014 - 2026)

Updated

Avalo Therapeutics (AVTX) posted Other Non-Current Assets of $183,000 for Q2 2026, down 12.9% from $210,000 a year earlier and unchanged from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Other Non-Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Avalo Therapeutics' Other Non-Current Assets came in at $210,000, up 60.3% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 7.1% (FY2020 to FY2025).
  • In prior years, Avalo Therapeutics' Other Non-Current Assets was $131,000 in FY2024 (unchanged), $131,000 in FY2023 (unchanged), $131,000 in FY2022 (-42.3%) and $227,000 in FY2021 (+52.3%).
  • Quarterly Other Non-Current Assets has run from a low of $131,000 in Q4 2022 to a high of $227,000 in Q2 2022 over five years.
  • On a year-over-year basis, Other Non-Current Assets increased in four of the last eight quarters, with growth averaging 26.0%.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q4 2025, with growth of 60.3%; the weakest was Q4 2022, with a decline of 42.3%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $183,000 (Q1 2026), $210,000 (Q4 2025) and $210,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Avalo Therapeutics 668.42 Mn 668.42 Mn - 183,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 183,000.00
Mar 31, 2026 183,000.00
Dec 31, 2025 210,000.00
Sep 30, 2025 210,000.00
Jun 30, 2025 210,000.00
Mar 31, 2025 131,000.00
Dec 31, 2024 131,000.00
Sep 30, 2024 131,000.00
Jun 30, 2024 131,000.00
Mar 31, 2024 131,000.00
Dec 31, 2023 131,000.00
Sep 30, 2023 131,000.00
Jun 30, 2023 131,000.00
Mar 31, 2023 131,000.00
Dec 31, 2022 131,000.00
Sep 30, 2022 181,000.00
Jun 30, 2022 227,000.00
Mar 31, 2022 227,000.00
Dec 31, 2021 227,000.00
Sep 30, 2021 227,000.00
API Access

Avalo Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AVTX&period=max&api_key=YOUR_API_KEY